Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > R-107 is approved for treatment of humans
View:
Post by whisky11 on Aug 31, 2021 10:58am

R-107 is approved for treatment of humans

on a small scale in the laboratory and hospital. It worked on the large animals having the same response system as humans.
They have money and laboratory willing to do it.
If they finish phase 1 we are talking big money. Personally my wishful thinking would be that they go along with their  nondilutive banking loans.
Comment by Chritters on Aug 31, 2021 11:21am
What Large Animals did it work on?
Comment by Amazigh on Aug 31, 2021 12:48pm
If I remember well. Toxicology studies were done on dogs. Sheep were included in PAH studies.
Comment by Chritters on Aug 31, 2021 12:57pm
Can you post the Link?
Comment by Amazigh on Aug 31, 2021 1:11pm
Sheep: https://ceo.ca/@nasdaq/claritas-announces-additional-data-in-validated-animal Dogs: https://ceo.ca/@nasdaq/claritas-announces-completion-of-canine-toxicology
Claritas Pharmaceuticals Inc